Close menu




December 27th, 2021 | 10:45 CET

Mutares, Hong Lai Huat, Aurelius - Yield generators in 2022!

  • Investments
Photo credits: pixabay.com

Given high inflation, investing in tangible assets such as shares, real estate, and commodities is still a good idea in 2022. Substantial stocks from the investment or real estate sector that create added value for shareholders and pay attractive dividends are now worth a closer look. We checked three different companies.

time to read: 2 minutes | Author: Carsten Mainitz
ISIN: MUTARES KGAA NA O.N. | DE000A2NB650 , HONG LAI HUAT GROUP LIMITED | SG1EE1000009 , AURELIUS EQ.OPP. O.N. | DE000A0JK2A8

Table of contents:


    Mutares - All signs point to growth!

    The private equity investor acquires small to medium-sized companies and parts of groups in situations of transition, based in Europe, which have clear operational improvement potential. Mutares actively supports and develops the portfolio companies with its investment and expert teams as well as through strategic add-on acquisitions. After stabilization and repositioning, the companies are sold with a target return of 7 to 10 times the invested capital.

    In 2021, the Munich-based Company acquired 13 companies. Most recently, the footprint in Scandinavia was significantly increased in Goods & Services. In the current fiscal year, sales are expected to increase to at least EUR 2.4 billion. The Company reported in its Q3 figures that the transaction pipeline is very well filled with a sales volume of EUR 9 billion. As guidance for 2023, Mutares has set its sights on consolidated revenues of at least EUR 5 billion. With the portfolio growth, consulting revenues are also increasing, which together with portfolio dividends and exit proceeds are accruing to the Company.

    Shareholders will participate in the Company's success based on a transparent and attractive dividend policy. The medium- to long-term plan is to pay out 1.8% to 2.2% of Group sales. The sustainable dividend policy is to consist of a basic dividend and an exit-dependent performance dividend. If the medium-term targets are only half achieved, investors will be buying a stock today that should generate an annual dividend yield of well over 10% in a few years. Analysts believe the shares have an upside potential of more than 40%.

    Hong Lai Huat - Still undiscovered small-cap

    Hong Lai Huat Group Limited has been operating as a real estate developer and property developer in Singapore, which is also the Company's headquarters, since 1998. The island nation is one of Asia's most important financial centers and a central shipping hub. Singapore has first-class marks in quality of life, security and economic performance. The home ownership rate is a good 90%.

    In recent decades, the Group has completed numerous projects in the city-state, ranging from public and private residential developments to commercial and industrial buildings. Implemented projects in Singapore include D'Ecosia, D'Fresco, D'Castilia, D'Almira, D'Lithium, D'Kranji Farm Resort and D'Centennial.

    In 2008, the Group diversified into the agricultural sector in Cambodia and has since completed the development of approximately 10,000 hectares of farmland growing fresh cassava. The Group has also expanded its real estate development in Cambodia with the successful launch of its first mixed-use condominium project, D'Seaview. D'Seaview comprises 737 residential units and 67 commercial units. Recently, the Singaporeans announced the complete project sale. With a market value of SGD 50 million, investors should put the still unknown stock on their watchlist.

    Aurelius - 30% discount to NAV

    Like Mutares, Aurelius can also look back on a record year, as is evidenced by the Q3 figures. In the first nine months of the current financial year, the operating result (EBITDA) increased by 81% to EUR 181.4 million and is thus above the 2020 total profit. The basis for the increase was the dynamic development of the portfolio companies. The intrinsic value per share (net asset value) increased by 20% compared to the end of 2020 to EUR 40.43. The shares are thus trading at a discount of around 30% compared to this key figure. Aurelius took advantage of the valuation level and announced the acquisition of 1 million own shares.


    Investment companies and real estate companies offer interesting investment opportunities. Mutares and Aurelius should continue to generate respectable returns for shareholders in the future. Hong Lai Huat, which is still widely unknown, belongs on the watch list for next year.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Armin Schulz on January 26th, 2022 | 11:17 CET

    Novavax, CoinSmart, Netflix - A buy after significant setbacks?

    • Investments

    The last few weeks have been tough for vaccine makers, cryptocurrencies and tech companies. In the case of vaccine manufacturers, concerns about a possible endemic disease caused by OmiCron was the reason for falling prices. In addition, there were the rumors about Pfizergate. Cryptocurrencies have been consolidating since early November. Allegedly, the US government is planning a crypto law, but contents are not yet known. For tech companies, the FED's expected interest rate hike, likely to be announced on January 26, brings uncertainty and makes investors rethink their investment strategy. Out of tech stocks, into value stocks. We look at one Company from each sector today.

    Read

    Commented by André Will-Laudien on January 20th, 2022 | 12:51 CET

    Alibaba, Hong Lai Huat, Tencent: Now things are really taking off!

    • Investments

    The Asia region remains on the growth path. The economies of China, Singapore, and Indonesia achieved 4.5 to 6.5% growth in 2021. Prosperity is not yet comparable with the West. But the developed zones around the metropolises have already shown high momentum for years. The real estate market, in particular, is booming in China as well as in Hong Kong, Singapore and Japan. It is uncertain how long the low interest rates will continue to support these markets because the Federal Reserve has already announced that it will exit the liquidity bubble. Who can surprise in the current environment?

    Read

    Commented by Mario Hose on January 20th, 2022 | 11:08 CET

    Cardiol, Novavax, Valneva - Why it's worth buying now!

    • Investments

    The trading week is coming to an end and on Thursday the German benchmark index DAX continues to trade below the psychological mark of 16,000 points at a level of 15,785 points and an increase of 0.10%. The rest of today and Friday remain to make a jump. It will probably depend on the guidance from the U.S., but at the hour, U.S. futures are all green. MDAX last traded at 34,135 points (+0.07%), TecDAX at 3,544 points (+0.07%) and SDAX at 15,626 points up 0.33%. Companies from the biotech sector are again in the focus of the investors today.

    Read